The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Wolff, A. C., Hammond, M. E. H., Hicks, D. G., Dowsett, M., McShane, L. M., Allison, K. H., Allred, D. C., Bartlett, J. M. S., Bilous, M., Fitzgibbons, P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.9984 · Cited by 4,030
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Giuliano, A. E. (2011) · JAMA · doi:10.1001/jama.2011.90 · Cited by 2,942
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, A., Pawlicki, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910383 · Cited by 2,775
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614 · cited 1×
“In most Western countries, the mortality rate has decreased in recent years, especially in younger age groups, because of improved treatment and earlier detection [3, 4].”
Gianni, L., Pienkowski, T., Im, Y.-H., Roman, L., Tseng, L.-M., Liu, M.-C., Lluch, A., Staroslawska, E., de la Haba-Rodriguez, J., Im, S.-A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70336-9 · Cited by 2,374
EBCTCG (Early Breast Cancer Trialists' Collaborative Group) (2014) · The Lancet · doi:10.1016/s0140-6736(14)60488-8 · Cited by 2,254
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H., Hagerty, K., Beck, L. N., Brennan, L. V., & Oktay, K. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5888 · Cited by 2,048
Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, M., Alencar, V. H. M., Badran, A., Bonfill, X., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61963-1 · Cited by 2,044
Dowsett, M., Nielsen, T. O., A'Hern, R., Bartlett, J., Coombes, R. C., Cuzick, J., Ellis, M., Henry, N. L., Hugh, J. C., Lively, T., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr393 · Cited by 1,977
Self-citationKrag, D. N., Anderson, S. J., Julian, T. B., Brown, A. M., Harlow, S. P., Costantino, J. P., Ashikaga, T., Weaver, D. L., Mamounas, E. P., Jalovec, L. M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70207-2 · Cited by 1,920
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Whelan, T. J., Pignol, J.-P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906260 · Cited by 1,878
Donker, M., van Tienhoven, G., Straver, M. E., Meijnen, P., van de Velde, C. J. H., Mansel, R. E., Cataliotti, L., Westenberg, A. H., Klinkenbijl, J. H. G., Orzalesi, L., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70460-7 · Cited by 1,871
Self-citationScreening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., André, F., Baselga, J., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv221 · Cited by 1,827
Self-citationGoss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Rastogi, P., Anderson, S. J., Bear, H. D., Geyer, C. E., Kahlenberg, M. S., Robidoux, A., Margolese, R. G., Hoehn, J. L., Vogel, V. G., Dakhil, S. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0235 · Cited by 1,789 · cited 1×
“In operable cases, the timing of treatment (preversus postoperative) has no effect on long-term outcomes [II, C] [122, 146].”
Physical activity and survival after breast cancer diagnosis
Holmes, M. D. (2005) · JAMA · doi:10.1001/jama.293.20.2479 · Cited by 1,772
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
Boughey, J. C. (2013) · JAMA · doi:10.1001/jama.2013.278932 · Cited by 1,588
Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C., Winer, E. P., Gradishar, W. J., Davidson, N. E., Martino, S., Livingston, R., Ingle, J. N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.081 · Cited by 1,564
European guidelines for quality assurance in breast cancer screening and diagnosis
Amendoeira, I., Perry, N., Broeders, M. J. M., de Wolf, C., Törnberg, S., Holland, R. D., & von Karsa, L. (2013) · Zurich Open Repository and Archive (University of Zurich) · doi:10.2772/13196 · Cited by 1,556
The benefits and harms of breast cancer screening: an independent review
(2012) · The Lancet · doi:10.1016/s0140-6736(12)61611-0 · Cited by 1,492
Kuehn, T., Bauerfeind, I., Fehm, T., Fleige, B., Hausschild, M., Helms, G., Lebeau, A., Liedtke, C., Minckwitz, G. V., Nekljudova, V., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70166-9 · Cited by 1,485
American Joint Committee On Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88443-1 · Cited by 1,386
Baselga, J., Bradbury, I., Eidtmann, H., Di Cosimo, S., de Azambuja, E., Aura, C., Gómez, H., Dinh, P., Fauria, K., Van Dooren, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61847-3 · Cited by 1,317
Regional Nodal Irradiation in Early-Stage Breast Cancer
Whelan, T. J., Olivotto, I. A., Parulekar, W. R., Ackerman, I., Chua, B. H., Nabid, A., Vallis, K. A., White, J. R., Rousseau, P., Fortin, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415340 · Cited by 1,294
Galimberti, V., Cole, B. F., Zurrida, S., Viale, G., Luini, A., Veronesi, P., Baratella, P., Chifu, C., Sargenti, M., Intra, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70035-4 · Cited by 1,233
(2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70077-9 · Cited by 1,132
Lyman, G. H., Temin, S., Edge, S. B., Newman, L. A., Turner, R. R., Weaver, D. L., Benson, A. B., Bosserman, L. D., Burstein, H. J., Cody, H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.1177 · Cited by 1,026
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Gnant, M., Mlineritsch, B., Schippinger, W., Luschin-Ebengreuth, G., Pöstlberger, S., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Bjelic-Radisic, V., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806285 · Cited by 1,025
von Minckwitz, G., Schneeweiss, A., Loibl, S., Salat, C., Denkert, C., Rezai, M., Blohmer, J. U., Jackisch, C., Paepke, S., Gerber, B., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70160-3 · Cited by 1,022
Sikov, W. M., Berry, D. A., Perou, C. M., Singh, B., Cirrincione, C. T., Tolaney, S. M., Kuzma, C. S., Pluard, T. J., Somlo, G., Port, E. R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.0572 · Cited by 1,013
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
Poortmans, P. M., Collette, S., Kirkove, C., Van Limbergen, E., Budach, V., Struikmans, H., Collette, L., Fourquet, A., Maingon, P., Valli, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415369 · Cited by 1,005
Self-citationRavdin, P. M., Siminoff, L. A., Davis, G. J., Mercer, M. B., Hewlett, J., Gerson, N., & Parker, H. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.980 · Cited by 996
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Sardanelli, F., Boetes, C., Borisch, B., Decker, T., Federico, M., Gilbert, F. J., Helbich, T., Heywang-Köbrunner, S. H., Kaiser, W. A., Kerin, M. J., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.015 · Cited by 992
Perez, E. A., Romond, E. H., Suman, V. J., Jeong, J.-H., Sledge, G., Geyer, C. E., Martino, S., Rastogi, P., Gralow, J., Swain, S. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5730 · Cited by 978
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., & Straif, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 962
Vaidya, J. S., Wenz, F., Bulsara, M., Tobias, J. S., Joseph, D. J., Keshtgar, M., Flyger, H. L., Massarut, S., Alvarado, M., Saunders, C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61950-9 · Cited by 831
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Dowsett, M., Cuzick, J., Ingle, J., Coates, A., Forbes, J., Bliss, J., Buyse, M., Baum, M., Buzdar, A., Colleoni, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1274 · Cited by 813
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Malin, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3756 · Cited by 796
Smith, I. E., Dowsett, M., Ebbs, S. R., Dixon, J. M., Skene, A., Blohmer, J.-U., Ashley, S. E., Francis, S., Boeddinghaus, I., & Walsh, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.005 · Cited by 774
Veronesi, U., Orecchia, R., Maisonneuve, P., Viale, G., Rotmensz, N., Sangalli, C., Luini, A., Veronesi, P., Galimberti, V., Zurrida, S., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70497-2 · Cited by 767
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Tolaney, S. M., Barry, W. T., Dang, C. T., Yardley, D. A., Moy, B., Marcom, P. K., Albain, K. S., Rugo, H. S., Ellis, M., Shapira, I., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406281 · Cited by 753
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
Pagani, O., Regan, M. M., Walley, B. A., Fleming, G. F., Colleoni, M., Láng, I., Gomez, H. L., Tondini, C., Burstein, H. J., Perez, E. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404037 · Cited by 749
Berry, D. A., Cirrincione, C., Henderson, I. C., Citron, M. L., Budman, D. R., Goldstein, L. J., Martino, S., Perez, E. A., Muss, H. B., Norton, L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1658 · Cited by 731
Offersen, B. V., Boersma, L. J., Kirkove, C., Hol, S., Aznar, M. C., Biete Sola, A., Kirova, Y. M., Pignol, J.-P., Remouchamps, V., Verhoeven, K., et al. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.11.030 · Cited by 728
Self-citationAdjuvant Ovarian Suppression in Premenopausal Breast Cancer
Francis, P. A., Regan, M. M., Fleming, G. F., Láng, I., Ciruelos, E., Bellet, M., Bonnefoi, H. R., Climent, M. A., Da Prada, G. A., Burstein, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412379 · Cited by 726
Eiermann, W., Paepke, S., Appfelstaedt, J., Llombart-Cussac, A., Eremin, J., Vinholes, J., Mauriac, L., Ellis, M., Lassus, M., Chaudri-Ross, H. A., et al. (2001) · Annals of Oncology · doi:10.1023/a:1013128213451 · Cited by 713
Bartelink, H., Maingon, P., Poortmans, P., Weltens, C., Fourquet, A., Jager, J., Schinagl, D., Oei, B., Rodenhuis, C., Horiot, J.-C., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71156-8 · Cited by 685
Self-citationRisch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P. A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj465 · Cited by 680
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Polgár, C., Limbergen, E. V., Pötter, R., Kovács, G., Polo, A., Lyczek, J., Hildebrandt, G., Niehoff, P., Guinot, J. L., Guedea, F., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.01.014 · Cited by 633
Weight Loss in Breast Cancer Patient Management
Chlebowski, R. T., Aiello, E. J., & McTiernan, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1128 · Cited by 623
Dowsett, M., Sestak, I., Lopez-Knowles, E., Sidhu, K., Dunbier, A. K., Cowens, J. W., Ferree, S., Storhoff, J., Schaper, C., & Cuzick, J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.1558 · Cited by 621
Gianni, L., Dafni, U., Gelber, R. D., Azambuja, E., Muehlbauer, S., Goldhirsch, A., Untch, M., Smith, I., Baselga, J., Jackisch, C., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70033-x · Cited by 612
Jones, S., Holmes, F. A., O'Shaughnessy, J., Blum, J. L., Vukelja, S. J., McIntyre, K. J., Pippen, J. E., Bordelon, J. H., Kirby, R. L., Sandbach, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.4028 · Cited by 588
Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
Warner, E., Messersmith, H., Causer, P., Eisen, A., Shumak, R., & Plewes, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00007 · Cited by 564
WHO Classification of Tumours: An Overview
Yakin, M., & Logan, R. (2025) · Pathological Basis of Oral and Maxillofacial Diseases · doi:10.1002/9781119989233.ch26 · Cited by 555
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Muss, H. B., Berry, D. A., Cirrincione, C. T., Theodoulou, M., Mauer, A. M., Kornblith, A. B., Partridge, A. H., Dressler, L. G., Cohen, H. J., Becker, H. P., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810266 · Cited by 554
Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy
Moore, H. C. F., Unger, J. M., Phillips, K.-A., Boyle, F., Hitre, E., Porter, D., Francis, P. A., Goldstein, L. J., Gomez, H. L., Vallejos, C. S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413204 · Cited by 553
Goldhirsch, A., Gelber, R. D., Piccart-Gebhart, M. J., de Azambuja, E., Procter, M., Suter, T. M., Jackisch, C., Cameron, D., Weber, H. A., Heinzmann, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61094-6 · Cited by 497
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
Korde, L. A., Zujewski, J. A., Kamin, L., Giordano, S., Domchek, S., Anderson, W. F., Bartlett, J. M. S., Gelmon, K., Nahleh, Z., Bergh, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5729 · Cited by 487
Self-citationGonzalez-Angulo, A. M., Litton, J. K., Broglio, K. R., Meric-Bernstam, F., Rakkhit, R., Cardoso, F., Peintinger, F., Hanrahan, E. O., Sahin, A., Guray, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2025 · Cited by 467
Self-citationJoensuu, H., Bono, P., Kataja, V., Alanko, T., Kokko, R., Asola, R., Utriainen, T., Turpeenniemi-Hujanen, T., Jyrkkiö, S., Möykkynen, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4577 · Cited by 458
Moran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.3935 · Cited by 451
Autier, P., Boniol, M., LaVecchia, C., Vatten, L., Gavin, A., Hery, C., & Heanue, M. (2010) · BMJ · doi:10.1136/bmj.c3620 · Cited by 412
Houssami, N., Macaskill, P., Marinovich, M. L., Dixon, J. M., Irwig, L., Brennan, M. E., & Solin, L. J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.043 · Cited by 406
Regan, M. M., Neven, P., Giobbie-Hurder, A., Goldhirsch, A., Ejlertsen, B., Mauriac, L., Forbes, J. F., Smith, I., Láng, I., Wardley, A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70270-4 · Cited by 406
Lohrisch, C., Paltiel, C., Gelmon, K., Speers, C., Taylor, S., Barnett, J., & Olivotto, I. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6089 · Cited by 373
Guarneri, V., Frassoldati, A., Bottini, A., Cagossi, K., Bisagni, G., Sarti, S., Ravaioli, A., Cavanna, L., Giardina, G., Musolino, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.0823 · Cited by 360
Cataliotti, L., Buzdar, A. U., Noguchi, S., Bines, J., Takatsuka, Y., Petrakova, K., Dube, P., & Tosello de Oliveira, C. (2006) · Cancer · doi:10.1002/cncr.21872 · Cited by 352
on behalf of the Austrian Breast and Colorectal Cancer Study Group (ABCSG), Dubsky, P., Brase, J. C., Jakesz, R., Rudas, M., Singer, C. F., Greil, R., Dietze, O., Luisser, I., Klug, E., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.671 · Cited by 350
Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors
Holmberg, L., Iversen, O.-E., Rudenstam, C. M., Hammar, M., Kumpulainen, E., Jaskiewicz, J., Jassem, J., Dobaczewska, D., Fjosne, H. E., Peralta, O., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn058 · Cited by 344
Jonat, W., Kaufmann, M., Sauerbrei, W., Blamey, R., Cuzick, J., Namer, M., Fogelman, I., de Haes, J. C., de Matteis, A., Stewart, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.042 · Cited by 341
Regan, M. M., Leyland-Jones, B., Bouzyk, M., Pagani, O., Tang, W., Kammler, R., Dell’Orto, P., Biasi, M. O., Thürlimann, B., Lyng, M. B., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs125 · Cited by 339
Pivot, X., Romieu, G., Debled, M., Pierga, J.-Y., Kerbrat, P., Bachelot, T., Lortholary, A., Espié, M., Fumoleau, P., Serin, D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70225-0 · Cited by 337
Screening for breast cancer with mammography
Gøtzsche, P. C., & Nielsen, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub4 · Cited by 311
Cardoso, F., Loibl, S., Pagani, O., Graziottin, A., Panizza, P., Martincich, L., Gentilini, O., Peccatori, F., Fourquet, A., Delaloge, S., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.10.004 · Cited by 304
Self-citationColeman, R., Cameron, D., Dodwell, D., Bell, R., Wilson, C., Rathbone, E., Keane, M., Gil, M., Burkinshaw, R., Grieve, R., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70302-x · Cited by 300
Guiu, S., Michiels, S., André, F., Cortes, J., Denkert, C., Di Leo, A., Hennessy, B. T., Sorlie, T., Sotiriou, C., Turner, N., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds586 · Cited by 290
Yen, T. W. F., Hunt, K. K., Ross, M. I., Mirza, N. Q., Babiera, G. V., Meric‐Bernstam, F., Singletary, E. S., Symmans, W. F., Giordano, S. H., Feig, B. W., et al. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.11.012 · Cited by 285
Park, S., Koo, J. S., Kim, M. S., Park, H. S., Lee, J. S., Lee, J. S., Kim, S. I., & Park, B.-W. (2012) · The Breast · doi:10.1016/j.breast.2011.07.008 · Cited by 284
Eidtmann, H., de Boer, R., Bundred, N., Llombart-Cussac, A., Davidson, N., Neven, P., von Minckwitz, G., Miller, J., Schenk, N., & Coleman, R. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq217 · Cited by 281
von Minckwitz, G., Untch, M., Nüesch, E., Loibl, S., Kaufmann, M., Kümmel, S., Fasching, P. A., Eiermann, W., Blohmer, J.-U., Costa, S. D., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1228-x · Cited by 280
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2008) · The Lancet · doi:10.1016/s0140-6736(08)60069-0 · Cited by 279
Giuliano, A. E., Hawes, D., Ballman, K. V., Whitworth, P. W., Blumencranz, P. W., Reintgen, D. S., Morrow, M., Leitch, A. M., Hunt, K. K., McCall, L. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1034 · Cited by 276
Hwang, E. S., Lichtensztajn, D. Y., Gomez, S. L., Fowble, B., & Clarke, C. A. (2013) · Cancer · doi:10.1002/cncr.27795 · Cited by 258
Albain, K. S., Barlow, W. E., Ravdin, P. M., Farrar, W. B., Burton, G. V., Ketchel, S. J., Cobau, C. D., Levine, E. G., Ingle, J. N., Pritchard, K. I., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61523-3 · Cited by 258
(2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0783 · Cited by 244
Bossuyt, V., Provenzano, E., Symmans, W. F., Boughey, J. C., Coles, C., Curigliano, G., Dixon, J. M., Esserman, L. J., Fastner, G., Kuehn, T., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv161 · Cited by 240
Self-citationReid, D. M., Doughty, J., Eastell, R., Heys, S. D., Howell, A., McCloskey, E. V., Powles, T., Selby, P., & Coleman, R. E. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.007 · Cited by 228
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
Drukker, C. A., Bueno‐de‐Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Roumen, R. M. H., Knauer, M., van 't Veer, L. J., Sonke, G. S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28082 · Cited by 227
Self-citationDavidson, N. E., O'Neill, A. M., Vukov, A. M., Osborne, C. K., Martino, S., White, D. R., & Abeloff, M. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.551 · Cited by 227
Pagani, O., O’Neill, A., Castiglione, M., Gelber, R. D., Goldhirsch, A., Rudenstam, C.-M., Lindtner, J., Collins, J., Crivellari, D., Coates, A., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10036-3 · Cited by 227
Gianni, L., Baselga, J., Eiermann, W., Porta, V. G., Semiglazov, V., Lluch, A., Zambetti, M., Sabadell, D., Raab, G., Cussac, A. L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2567 · Cited by 220
Surgical guidelines for the management of breast cancer
Association of Breast Surgery at (2009) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2009.01.008 · Cited by 212
Quality indicators in breast cancer care
Rosselli Del Turco, M., Ponti, A., Bick, U., Biganzoli, L., Cserni, G., Cutuli, B., Decker, T., Dietel, M., Gentilini, O., Kuehn, T., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.119 · Cited by 207
Self-citationBehavioral Risk Factors in Breast Cancer: Can Risk Be Modified?
McTiernan, A. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-326 · Cited by 193
Harbeck, N., Kates, R. E., Look, M. P., Gelder, M. E. M., Klijn, J. G. M., Krüger, A., Kiechle, M. B., Jänicke, F., Schmitt, M., & Foekens, J. A. (2002) · PubMed · Cited by 191
Goss, P. E., Ingle, J. N., Pater, J. L., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Shepherd, L. E., Pritchard, K. I., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6798 · Cited by 191
Ottini, L., Palli, D., Rizzo, S., Federico, M., Bazan, V., & Russo, A. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.04.003 · Cited by 190
Pruthi, S., Gostout, B. S., & Lindor, N. M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0414 · Cited by 189
The requirements of a specialist Breast Centre
Wilson, A. R. M., Marotti, L., Bianchi, S., Biganzoli, L., Claassen, S., Decker, T., Frigerio, A., Goldhirsch, A., Gustafsson, E. G., Mansel, R. E., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.07.017 · Cited by 179
Self-citationMammographic Screening Programmes in Europe: Organization, Coverage and Participation
Giordano, L., Von Karsa, L., Tomatis, M., Majek, O., De Wolf, C., Lancucki, L., Hofvind, S., Nystrom, L., Segnan, N., & Ponti, A. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012085 · Cited by 178
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
Eggemann, H., Ignatov, A., Smith, B. J., Altmann, U., von Minckwitz, G., Röhl, F. W., Jahn, M., & Costa, S.-D. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2355-3 · Cited by 164
Current management of lesions associated with an increased risk of breast cancer
Morrow, M., Schnitt, S. J., & Norton, L. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.8 · Cited by 160
First international consensus guidelines for breast cancer in young women (BCY1)
Partridge, A. H., Pagani, O., Abulkhair, O., Aebi, S., Amant, F., Azim, H. A., Costa, A., Delaloge, S., Freilich, G., Gentilini, O. D., et al. (2014) · The Breast · doi:10.1016/j.breast.2014.03.011 · Cited by 159
Self-citationKoolen, B. B., Peeters, M.-J. T. F. D. V., Aukema, T. S., Vogel, W. V., Oldenburg, H. S. A., van der Hage, J. A., Hoefnagel, C. A., Stokkel, M. P. M., Loo, C. E., Rodenhuis, S., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1767-9 · Cited by 158
Self-citationCoprescription of Tamoxifen and Medications That Inhibit CYP2D6
Sideras, K., Ingle, J. N., Ames, M. M., Loprinzi, C. L., Mrazek, D. P., Black, J. L., Weinshilboum, R. M., Hawse, J. R., Spelsberg, T. C., & Goetz, M. P. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.8931 · Cited by 155
Weaver, D. L. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.36 · Cited by 154
Azim, H. A., Michiels, S., Zagouri, F., Delaloge, S., Filipits, M., Namer, M., Neven, P., Symmans, W. F., Thompson, A. M., André, F., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds645 · Cited by 145
Mann, G. B., Fahey, V., Feleppa, F., & Buchanan, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.076 · Cited by 138
Bliss, J. M., Kilburn, L., Coleman, R. E., Forbes, J., Coates, A. S., Jones, S. E., Jassem, J., Delozier, T., ANDERSEN, J. E., Paridaens, R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7899 · Cited by 130
A population-based validation of the prognostic model PREDICT for early breast cancer
Wishart, G. C., Bajdik, C. D., Azzato, E. M., Dicks, E., Greenberg, D. C., Rashbass, J., Caldas, C. H., & Pharoah, P. D. P. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.02.001 · Cited by 129
Earl, H. M., Vallier, A.-L., Hiller, L., Fenwick, N., Young, J., Iddawela, M. Y., Abraham, J., Hughes‐Davies, L., Gounaris, I., McAdam, K., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70554-0 · Cited by 119
Kyndi, M., Overgaard, M., Nielsen, H. M., Sørensen, F. B., Knudsen, H., & Overgaard, J. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.04.014 · Cited by 115
Chen, X., Yuan, Y., Gu, Z.-X., & Shen, K. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1990-z · Cited by 112
Chatterjee, J. S., Lee, A., Anderson, W., Baker, L., Stevenson, J. H., Dewar, J. A., & Thompson, A. M. (2009) · British journal of surgery · doi:10.1002/bjs.6693 · Cited by 95
Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow
Harbeck, N., Sotlar, K., Wuerstlein, R., & Doisneau-Sixou, S. F. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.09.014 · Cited by 94
Adams, S., Chakravarthy, A. B., Donach, M. E., SPICER, D. V., Lymberis, S. C., Singh, B., Bauer, J. A., Hochman, T., Goldberg, J. D., Muggia, F. M., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1181-8 · Cited by 92
Allemani, C., Minicozzi, P., Berrino, F., Bastiaannet, E., Gavin, A., Galcerán, J., Ameijide, A., Siesling, S., Mangone, L., Ardanáz, E., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27895 · Cited by 91
Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate
Poortmans, P. M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60192-6 · Cited by 80
Self-citationAn update on male breast cancer and future directions for research and treatment
Sousa, B., Moser, E. C., & Cardoso, F. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.037 · Cited by 78
Self-citationLiebens, F., Carly, B., Pastijn, A., & Rozenberg, S. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.07.019 · Cited by 78
Senkus, E., Gómez, H., Dirix, L. Y., Jérusalem, G., Murray, E., van Tienhoven, G., Westenberg, A. H., Bottomley, A., Rapion, J., Bogaerts, J., et al. (2013) · Psycho-Oncology · doi:10.1002/pon.3384 · Cited by 77
Self-citationMeijnen, P., Oldenburg, H. S. A., Loo, C. E., Nieweg, O. E., Peterse, J. L., & Rutgers, E. J. T. (2007) · British journal of surgery · doi:10.1002/bjs.5735 · Cited by 77
Self-citationGebruers, N., Verbelen, H., Vrieze, T. D., Coeck, D., & Tjalma, W. A. A. (2015) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2015.01.014 · Cited by 76
FDG-PET/CT in the staging of local/regional metastases in breast cancer
Robertson, I., Hand, F., & Kell, M. (2011) · The Breast · doi:10.1016/j.breast.2011.07.002 · Cited by 75
Perrone, F., Nuzzo, F., Rella, F. D., Gravina, A., Iodice, G., Labonia, V., Landi, G., Pacilio, C., Rossi, E., Laurentiis, M. D., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu564 · Cited by 73
Moore, K. M. H., Sweeney, K., Wilson, M., Goldberg, J., Buchanan, C. L., Tan, L. K., Liberman, L., Turner, R. R., Lagios, M. D., Cody, H. S., et al. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9414-8 · Cited by 72
Amenorrhea from Breast Cancer Therapy — Not a Matter of Dose
Swain, S. M., Jeong, J., & Wolmark, N. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1009616 · Cited by 72
van Werkhoven, E. D., Hart, G. A. M., van Tinteren, H., Elkhuizen, P. H. M., Collette, L., Poortmans, P. M., & Bartelink, H. G. M. M. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.07.004 · Cited by 67
Self-citationPoortmans, P. M., Aznar, M. C., & Bartelink, H. G. M. M. (2011) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2011.09.007 · Cited by 66
Self-citationPostoperative tamoxifen for ductal carcinoma in situ
Staley, H., McCallum, I. J. D., & Bruce, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007847.pub2 · Cited by 58
Goodwin, A., Parker, S. M., Ghersi, D., & Wilcken, N. R. C. (2009) · The Breast · doi:10.1016/j.breast.2009.04.003 · Cited by 57
Reading the prognosis of the individual with breast cancer
Blamey, R. W., Pinder, S. E., Ball, G., Ellis, I. O., Elston, C. W., Mitchell, M. J., & Haybittle, J. L. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.01.003 · Cited by 57
Crivellari, D., Gray, K. P., Dellapasqua, S., Puglisi, F., Ribi, K., Price, K. N., Láng, I., Gianni, L., Spazzapan, S., Pinotti, G., et al. (2013) · The Breast · doi:10.1016/j.breast.2013.01.015 · Cited by 56
ASCO-CAP Guidelines for Breast Predictive Factor Testing
Hammond, M. E. H. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31822a8eac · Cited by 52
Shao, N., Wang, S., Chen, Y., Xu, X., Zhang, Y., Zhang, Y., & Lin, Y. (2012) · The Breast · doi:10.1016/j.breast.2012.03.011 · Cited by 46
Tumour‐positive sentinel node findings in patients with ductal carcinoma in situ
Leidenius, M., Salmenkivi, K., von Smitten, K., & Heikkilä, P. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20581 · Cited by 42
Schnitt, S. J., Moran, M. S., Houssami, N., & Morrow, M. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0384-ed · Cited by 33
Radiotherapy for breast cancer in patients undergoing breast reconstruction or augmentation
Senkus, E., Wełnicka-Jaśkiewicz, M., Jaśkiewicz, J., & Jassem, J. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.06.008 · Cited by 26
Self-citationEmerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine
Wazir, U. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i5.795 · Cited by 13
Cited by
Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer
Schmid, P., Adams, S., Rugo, H. S., Schneeweiss, A., Barrios, C. H., Iwata, H., Diéras, V., Hegg, R., Im, S.-A., Shaw Wright, G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809615 · Cited by 4,350
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Self-citationTrastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
von Minckwitz, G., Huang, C.-S., Mano, M. S., Loibl, S., Mamounas, E. P., Untch, M., Wolmark, N., Rastogi, P., Schneeweiss, A., Redondo, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814017 · Cited by 2,625
Schmid, P., Rugo, H. S., Adams, S., Schneeweiss, A., Barrios, C. H., Iwata, H., Diéras, V., Henschel, V., Molinero, L., Chui, S. Y., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30689-8 · Cited by 1,216
Johnston, S. R. D., Harbeck, N., Hegg, R., Toi, M., Martin, M., Shao, Z. M., Zhang, Q. Y., Martinez Rodriguez, J. L., Campone, M., Hamilton, E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.02514 · Cited by 1,022
Metadata
- Authors
- Senkus, E., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rutgers, E., Zackrisson, S., & Cardoso, F.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 26
- Pages
- v8-v30
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4252714226
- Cited by
- 1,597
- References
- 150
- FWCI
- 51.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.